- Bupa Platinum consultant
- Fee assured
- Awaiting verification
- Open Referral network
- Video and telephone consultations
- Home chemotherapy
I am a medical oncologist with a particular interest in advanced melanoma and urological cancers. This includes testicular cancer, kidney cancer, prostate cancer and bladder cancer.
I completed my specialty training in medical oncology in Wessex and Bristol and undertook a 3 year Cancer Research UK research fellowship at the University of Southampton investigating signalling pathways in kidney cancer.
I was appointed as an NHS consultant at University Hospital Southampton in 2011.
Areas of interest
• Urological oncology • Malignant melanoma • Germ cell tumours
- Lyn Corlass
- Spire Southampton Hospital Chalybeate Close Southampton SO16 6UY
- 023 8076 4979
Current NHS consultant posts held
Consultant Medical Oncologist, University Hospital Southampton
My research interests focus on systemic therapies for advanced cancer. I am a member of the National Cancer Research Institute Testicular Cancer studies group and have recently completed a national chemotherapy trial investigating chemotherapy drugs for testicular cancer which has returned after initial chemotherapy. I am a local investigator for a number of national and international trials investigating new treatment approaches in melanoma and kidney cancer.
- BM University of Southampton 1998
- FRCP Royal College of Physicians 2016
- PhD University of Southampton 2011
Reference number 4520577
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
Information for healthcare professionals (Bupa patients only, last 12 months)
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (>50)
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)
Spire Southampton Hospital (5-50)
Clinical supervision and planning for delivery of chemotherapy cycle, remote or in the member's home 1-28 days - (5-50)
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-14 days - (5-50)
Follow-up out-patient consultation - remote - (1-5)